UBS Group reaffirmed their sell rating on shares of Johnson Matthey (LON:JMAT) in a report issued on Tuesday, ThisIsMoney.Co.Uk reports.
JMAT has been the subject of several other reports. Berenberg Bank reaffirmed a buy rating on shares of Johnson Matthey in a research note on Tuesday, August 20th. Deutsche Bank reaffirmed a buy rating on shares of Johnson Matthey in a research note on Thursday, July 18th. Liberum Capital reaffirmed a buy rating on shares of Johnson Matthey in a research note on Monday, September 16th. Credit Suisse Group started coverage on shares of Johnson Matthey in a research note on Monday, September 2nd. They set an outperform rating and a GBX 4,200 ($54.88) price objective for the company. Finally, HSBC upped their price objective on shares of Johnson Matthey from GBX 3,650 ($47.69) to GBX 3,750 ($49.00) and gave the company a buy rating in a research note on Wednesday, June 5th. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. The company currently has an average rating of Buy and an average price target of GBX 3,804.29 ($49.71).
Shares of LON:JMAT opened at GBX 3,100 ($40.51) on Tuesday. The company has a market cap of $6.00 billion and a price-to-earnings ratio of 14.45. The company has a 50-day moving average price of GBX 2,983.26 and a 200-day moving average price of GBX 3,160.17. The company has a current ratio of 1.64, a quick ratio of 0.95 and a debt-to-equity ratio of 50.40. Johnson Matthey has a 12 month low of GBX 2,574 ($33.63) and a 12 month high of GBX 3,692 ($48.24).
In related news, insider Anna Manz purchased 12 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was bought at an average cost of GBX 2,845 ($37.17) per share, with a total value of £341.40 ($446.10). Also, insider Robert MacLeod sold 6,696 shares of the stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of GBX 3,166 ($41.37), for a total transaction of £211,995.36 ($277,009.49). Over the last ninety days, insiders have bought 36 shares of company stock valued at $110,472.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Read More: Backdoor Roth IRA
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.